Normal view MARC view ISBD view

Advancing Cardiac Surgery Case Planning and Case Review Conferences Using Virtual Reality in Medical Libraries: Evaluation of the Usability of Two Virtual Reality Apps. [electronic resource]

By:

Napa, Sandeep

Contributor(s):

Publication details: JMIR human factors Jan 2019Description: e12008 p. digitalISSN:

2292-9495

Online resources:

Available from publisher's website

In: JMIR human factors vol. 6

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Ireland and its drink problem: the immediate adverse effects of binge drinking in Ireland.
by O'Farrell, Anne
2 Comparison of the health and well-being of smoking and non-smoking school-aged children in Ireland.
by Evans, David S
3 Alcohol use among amateur sportsmen in Ireland.
by O'Farrell, Anne M
4 A multi-faceted intervention to reduce alcohol misuse and harm amongst sports people in Ireland: A controlled trial.
by O'Farrell, Anne
5 Trends in the incidence of lower extremity amputations in people with and without diabetes over a five-year period in the Republic of Ireland.
by Buckley, Claire M
6 Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells.
by Yee, Kevin W H
7 Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification.
by DePrimo, Samuel E
8 SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase.
by Yee, Kevin W H
9 A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.
by Sohal, Jastinder
10 SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model.
by Murray, Lesley J
11 Child Health Care in Ireland.
by Staines, Anthony
12 Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.
by O'Farrell, Anne-Marie
13 A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia.
by Fiedler, Walter
14 SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity.
by Patyna, Shem
15 A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.
by Fiedler, Walter
16 SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo.
by O'Farrell, Anne-Marie
17 An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.
by O'Farrell, Anne-Marie
18 SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes.
by Giles, Francis J
19 A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.
by Parham, Christi